Client Testimonials
Therapeutic Proteins
Major Pharma Company
"John is the best in his field. His work is meticulous,
timely, and high value"
Major Biotech
Corporation
"John Adair is an outstanding scientist, he delivered the
necessary scientific advice, asked the right questions, provided
majority of prior art."
Apposite Capital
"John was our only choice to deliver the required sector
expertise. He hits the sweet spot". Apposite "will definitely use
Ithaka again for any project in this sector."
Biomarkers
Psynova Neurotech, Prof. Sabine
Bahn, Director/ Co-Founder
"Paul has played a significant role in helping take
Psynova Neurotech from a concept through to the launch of
VeriPsychâ„¢, the first and only blood test to aid a psychiatrist in
the diagnosis of recent-onset schizophrenia. As Chairman of the
Board he has provided wise advice and support across all aspects of
the business. He has been a delight to work with and his efforts
are greatly appreciated by all the team at Psynova."
Commercialising Novel Technology - Universities
School of Marine Science &
Technology, University of Newcastle Prof Grant
Burgess,
"I have been very impressed by the market analysis undertaken by
Ithaka around the potential value of our developing technology for
the prevention and removal of bacterial biofilm. The information
has been tremendously useful in providing the insight required to
help take forward the research and in structuring deals and
projects across a range of applications."
Strategic review
Local Enterprise Partnership in the North of
England, 2011
"Thank you for all your hard work on this strategic review; we are
very pleased with the breadth and depth of the research and the way
in which Ithaka has engaged with so many different organisations
across education, health and industry to produce our report."